These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30011115)

  • 1. Synthesis of Structurally Diverse N-Substituted Quaternary-Carbon-Containing Small Molecules from α,α-Disubstituted Propargyl Amino Esters.
    Mateu N; Kidd SL; Kalash L; Sore HF; Madin A; Bender A; Spring DR
    Chemistry; 2018 Sep; 24(51):13681-13687. PubMed ID: 30011115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity-Oriented Synthesis and Chemoinformatic Analysis of the Molecular Diversity of sp
    Lenci E; Innocenti R; Menchi G; Trabocchi A
    Front Chem; 2018; 6():522. PubMed ID: 30425982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinyl and Alkynyl Substituted Heterocycles as Privileged Scaffolds in Transition Metal Promoted Stereoselective Synthesis.
    Ghorai D; Tóth BL; Lanzi M; Kleij AW
    Acc Chem Res; 2024 Mar; 57(5):726-738. PubMed ID: 38387878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Applications of Diversity-Oriented Synthesis Toward Novel, 3-Dimensional Fragment Collections.
    Kidd SL; Osberger TJ; Mateu N; Sore HF; Spring DR
    Front Chem; 2018; 6():460. PubMed ID: 30386766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity-oriented synthesis of macrocyclic peptidomimetics.
    Isidro-Llobet A; Murillo T; Bello P; Cilibrizzi A; Hodgkinson JT; Galloway WR; Bender A; Welch M; Spring DR
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6793-8. PubMed ID: 21383137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.
    Galloway WR; Isidro-Llobet A; Spring DR
    Nat Commun; 2010 Sep; 1():80. PubMed ID: 20865796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds.
    Isidro-Llobet A; Hadje Georgiou K; Galloway WR; Giacomini E; Hansen MR; Méndez-Abt G; Tan YS; Carro L; Sore HF; Spring DR
    Org Biomol Chem; 2015 Apr; 13(15):4570-80. PubMed ID: 25778821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multidimensional Diversity-Oriented Synthesis Strategy for Structurally Diverse and Complex Macrocycles.
    Nie F; Kunciw DL; Wilcke D; Stokes JE; Galloway WR; Bartlett S; Sore HF; Spring DR
    Angew Chem Int Ed Engl; 2016 Sep; 55(37):11139-43. PubMed ID: 27484830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel complexity-to-diversity strategy for the diversity-oriented synthesis of structurally diverse and complex macrocycles from quinine.
    Ciardiello JJ; Stewart HL; Sore HF; Galloway WRJD; Spring DR
    Bioorg Med Chem; 2017 Jun; 25(11):2825-2843. PubMed ID: 28283333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrates in diversity-oriented synthesis: challenges and opportunities.
    Lenci E; Menchi G; Trabocchi A
    Org Biomol Chem; 2016 Jan; 14(3):808-25. PubMed ID: 26632306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Synthetic Methodologies via Catalytic Enantioselective Synthesis of 3,3-Disubstituted Oxindoles.
    Cao ZY; Zhou F; Zhou J
    Acc Chem Res; 2018 Jun; 51(6):1443-1454. PubMed ID: 29808678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydride-Abstraction-Initiated Catalytic Stereoselective Intermolecular Bond-Forming Processes.
    Liu L
    Acc Chem Res; 2022 Dec; 55(23):3537-3550. PubMed ID: 36384272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity oriented synthesis: a challenge for synthetic chemists.
    Bender A; Fergus S; Galloway WR; Glansdorp FG; Marsden DM; Nicholson RL; Spandl RJ; Thomas GL; Wyatt EE; Glen RC; Spring DR
    Ernst Schering Res Found Workshop; 2006; (58):47-60. PubMed ID: 16708998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-oriented and diversity-oriented organic synthesis in drug discovery.
    Schreiber SL
    Science; 2000 Mar; 287(5460):1964-9. PubMed ID: 10720315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
    Kim J; Kim H; Park SB
    J Am Chem Soc; 2014 Oct; 136(42):14629-38. PubMed ID: 25310802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic Asymmetric Reactions with
    Wei L; Chang X; Wang CJ
    Acc Chem Res; 2020 May; 53(5):1084-1100. PubMed ID: 32320206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of 56 Shape-Diverse 3D Fragments.
    Downes TD; Jones SP; Klein HF; Wheldon MC; Atobe M; Bond PS; Firth JD; Chan NS; Waddelove L; Hubbard RE; Blakemore DC; De Fusco C; Roughley SD; Vidler LR; Whatton MA; Woolford AJ; Wrigley GL; O'Brien P
    Chemistry; 2020 Jul; 26(41):8969-8975. PubMed ID: 32315100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaffold Diversity Synthesis Delivers Complex, Structurally, and Functionally Distinct Tetracyclic Benzopyrones.
    Sankar MG; Roy S; Tran TTN; Wittstein K; Bauer JO; Strohmann C; Ziegler S; Kumar K
    ChemistryOpen; 2018 Apr; 7(4):302-309. PubMed ID: 29721402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Route to three-dimensional fragments using diversity-oriented synthesis.
    Hung AW; Ramek A; Wang Y; Kaya T; Wilson JA; Clemons PA; Young DW
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6799-804. PubMed ID: 21482811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A planning strategy for diversity-oriented synthesis.
    Burke MD; Schreiber SL
    Angew Chem Int Ed Engl; 2004 Jan; 43(1):46-58. PubMed ID: 14694470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.